PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells

Wang,Feifei; Wang,Lin; Pan,Jihong

doi:10.3892/mmr.2014.2691

PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells

Authors:
- Feifei Wang
- Lin Wang
- Jihong Pan
View Affiliations

Affiliations: Shandong Medicinal and Biotechnology Center, Shandong Academy of Medical Sciences, Jinan, Shandong 250062, P.R. China
Published online on: October 17, 2014 https://doi.org/10.3892/mmr.2014.2691
Pages: 698-704

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

PACE4 is one of the proprotein convertases (PC) that participate in the post-translational activation of inactive proteins, leading to mature, biologically active proteins. The processing reactions occur in pairs of basic amino acids. PACE4 is an extracellular PC that binds to growth factors and several components of the extracellular matrix contributing to tumor progression. In the present study, the PACE4 gene was silenced by small interfering RNA (siRNA), and the knockdown human breast cancer MDA-MB-231 cells showed significantly reduced proliferation, migration and invasion rates. Flow cytometry analysis indicated that downregulation of PACE4 increases the percentage of cells arrested at the G0/G1 phase. Moreover, the expression of genes involved in cell growth, invasion and adhesion, i.e., IGF-2, MMP9 and MPZL2 was significantly decreased following siRNA‑mediated silencing of PACE4. Taken together, these results indicate that PACE4 plays an important role in human breast cancer, and that it might represent a novel target for breast cancer therapy.

View Figures

View References

1	Seidah NG and Chrétien M: Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res. 848:45–62. 1999. View Article : Google Scholar : PubMed/NCBI
2	Nagahama M, Taniguchi T, Hashimoto E, et al: Biosynthetic processing and quaternary interactions of proprotein convertase SPC4 (PACE4). FEBS Lett. 434:155–159. 1998. View Article : Google Scholar : PubMed/NCBI
3	Mains RE, Berard CA, Denault JB, et al: PACE4: a subtilisin-like endoprotease with unique properties. Biochem J. 321:587–593. 1997.PubMed/NCBI
4	Jensen RA, Thompson ME, Jetton TL, et al: BRCA1 is secreted and exhibits properties of a granin. Nat Genet. 12:303–308. 1996. View Article : Google Scholar : PubMed/NCBI
5	Walerych D, Napoli M, Collavin L and Del Sal G: The rebel angel: mutant p53 as the driving oncogene in breast cancer. Carcinogenesis. 33:2007–2017. 2012. View Article : Google Scholar : PubMed/NCBI
6	Bassi DE, Zhang J, Cenna J, et al: Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis. Neoplasia. 12:516–526. 2010.
7	Lapierre M, Siegfried G, Scamuffa N, et al: Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells’ malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. Cancer Res. 67:9030–9034. 2007.PubMed/NCBI
8	D’Anjou F, Routhier S, Perreault JP, et al: Molecular validation of PACE4 as a target in prostate cancer. Transl Oncol. 4:157–172. 2011.PubMed/NCBI
9	Tsuji A, Sakurai K, Kiyokage E, et al: Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix. Potential role of PACE4 in the activation of proproteins in the extracellular matrix. Biochim Biophys Acta. 1645:95–104. 2003. View Article : Google Scholar
10	Cheng M, Watson PH, Paterson JA, et al: Pro-protein convertase gene expression in human breast cancer. Int J Cancer. 71:966–971. 1997. View Article : Google Scholar : PubMed/NCBI
11	Hubbard FC, Goodrow TL, Liu SC, et al: Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability. Cancer Res. 57:5226–5231. 1997.PubMed/NCBI
12	Schalken JA, Roebroek AJ, Oomen PP, et al: fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas. J Clin Invest. 80:1545–1549. 1987. View Article : Google Scholar : PubMed/NCBI
13	Fu Y, Campbell EJ, Shepherd TG and Nachtigal MW: Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells. Mol Cancer Res. 1:569–576. 2003.PubMed/NCBI
14	Duguay SJ, Jin Y, Stein J, et al: Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem. 273:18443–18451. 1998. View Article : Google Scholar : PubMed/NCBI
15	Bassi DE, Lopez De Cicco R, Cenna J, et al: PACE4 expression in mouse basal keratinocytes results in basement membrane disruption and acceleration of tumor progression. Cancer Res. 65:7310–7319. 2005. View Article : Google Scholar : PubMed/NCBI
16	Guttinger M, Sutti F, Panigada M, et al: Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis. J Cell Biol. 141:1061–1071. 1998. View Article : Google Scholar
17	Dong S, Zhang Z and Takahara H: Estrogen-enhanced peptidylarginine deiminase type IVgene (PADI4) expression in MCF-7 cells is mediated estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1. Mol Endocrinol. 21:1617–1629. 2007. View Article : Google Scholar
18	Fu J, Bassi DE, Zhang J, et al: Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases. Neoplasia. 15:169–179. 2013.PubMed/NCBI